Phase III randomised trial comparing 6 vs. 12-month of capecitabine as adjuvant chemotherapy for patients with stage III colon cancer: final results of the JFMC37-0801 study

BACKGROUND: Up to 6-months oxaliplatin-containing regimen is now widely accepted as a standard adjuvant chemotherapy for stage III colorectal cancer (CRC). However, oral fluoropyrimidine monotherapy is used for some part of patients, especially in Asian countries including Japan, and its optimal dur...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Br J Cancer
Main Authors: Tomita, Naohiro, Kunieda, Katsuyuki, Maeda, Atsuyuki, Hamada, Chikuma, Yamanaka, Takeharu, Sato, Toshihiko, Yoshida, Kazuhiro, Boku, Narikazu, Nezu, Riichiro, Yamaguchi, Shigeki, Mishima, Hideyuki, Sadahiro, Sotaro, Muro, Kei, Ishiguro, Megumi, Sakamoto, Junichi, Saji, Shigetoyo, Maehara, Yoshihiko
Format: Artigo
Sprog:Inglês
Udgivet: Nature Publishing Group UK 2019
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6461756/
https://ncbi.nlm.nih.gov/pubmed/30833647
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-019-0410-0
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker